ClinicalTrials.gg
Drug

Rotigotine clinical trials

Also written Neupro and SPM 962.

studies test it
77
open now
2
in phase 3
33
first study started
1999

How each study uses rotigotine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the rotigotine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
9 May 2007 · NEUPRO · NDA 021829 (FDA, Drugs@FDA)
European Union
15 Feb 2006 · Neupro · EMEA/H/C/000626 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Rotigotine
48
Rotigotine transdermal patch
6
Rotigotine 4Mg/24Hrs Patch
2
(6S)-6-propyl-[2 (2 thienyl)ethyl]amino-5,6,7,8-tetrahydro-1-naphthalenol
2
Rotigotine Nasal Spray
2

Brand

Neupro
39

Development codes

SPM 962
13
SPM937
1

Studies by the year they started

77 studies that test it; most in 2012 (13)

Studies that test rotigotine, by start year
YearStudies
19991
20025
20031
20045
20056
20067
20077
20084
20093
20103
20115
201213
20133
20142
20164
20181
20192
20212
20232
20251

By phase

A phase 1/2 study counts in both.

Phase 1
14
Phase 2
20
Phase 3
33
Phase 4
11
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 64 · Other 13

UCB Pharma (36) · Otsuka Pharmaceutical Co., Ltd. (10) · UCB BIOSCIENCES GmbH (9) · I.R.C.C.S. Fondazione Santa Lucia (3) · UCB BIOSCIENCES, Inc. (2) · UCB Biopharma SRL (2) · Virginia Commonwealth University (1) · SocraTec R&D GmbH (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses rotigotine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 77

See all 77 studies that test rotigotine →

Given beside what is tested · 1 — rotigotine is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with rotigotine

Codes

What other systems call rotigotine · ClinicalTrials.gg INT003250

  • MeSH (NLM) C047508rotigotineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 87T4T8BO2EROTIGOTINEConfirmed FDA, NLM, Wikidata
  • UNII (FDA) 5QTR54Z0E1ROTIGOTINE, (+/-)-Confirmed NLM, Wikidata
  • UNII (FDA) N8FO6Z42IRROTIGOTINE, (+)-Confirmed NLM, Wikidata
  • RxNorm 616739Confirmed FDA, Wikidata
  • Wikidata Q411985(6S)-rotigotineConfirmed FDA, NLM, Wikidata
  • Wikidata Q27262758(+/-)-rotigotineConfirmed NLM, Wikidata
  • Wikidata Q27284704(+)-rotigotineConfirmed NLM, Wikidata
  • NCI Thesaurus C77566RotigotineOne source FDA
  • DrugBank DB05271One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.